Wedbush Securities’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.71M | Buy |
3,037
+1,205
| +66% | +$773K | 0.05% | 306 |
|
|
2025
Q4 | $1.24M | Sell |
1,832
-63
| -3% | -$42.9K | 0.04% | 382 |
|
|
2025
Q3 | $1.21M | Sell |
1,895
-299
| -14% | -$181K | 0.04% | 372 |
|
|
2025
Q2 | $1.18M | Buy |
2,194
+49
| +2% | +$23.4K | 0.04% | 368 |
|
|
2025
Q1 | $901K | Buy |
2,145
+28
| +1% | +$12.2K | 0.03% | 417 |
|
|
2024
Q4 | $875K | Sell |
2,117
-115
| -5% | -$50.4K | 0.03% | 418 |
|
|
2024
Q3 | $1.13M | Sell |
2,232
-26
| -1% | -$12.6K | 0.04% | 342 |
|
|
2024
Q2 | $1.1M | Sell |
2,258
-39
| -2% | -$19.6K | 0.04% | 350 |
|
|
2024
Q1 | $1.24M | Sell |
2,297
-16
| -0.7% | -$8.74K | 0.05% | 317 |
|
|
2023
Q4 | $1.28M | Sell |
2,313
-11
| -0.5% | -$5.16K | 0.06% | 264 |
|
|
2023
Q3 | $1.02M | Sell |
2,324
-88
| -4% | -$43.9K | 0.05% | 304 |
|
|
2023
Q2 | $1.21M | Sell |
2,412
-153
| -6% | -$73.3K | 0.06% | 276 |
|
|
2023
Q1 | $1.28M | Sell |
2,565
-127
| -5% | -$60.8K | 0.06% | 257 |
|
|
2022
Q4 | $1.1M | Sell |
2,692
-109
| -4% | -$42.3K | 0.06% | 283 |
|
|
2022
Q3 | $913K | Buy |
2,801
+517
| +23% | +$190K | 0.05% | 309 |
|
|
2022
Q2 | $801K | Sell |
2,284
-158
| -6% | -$64.4K | 0.04% | 353 |
|
|
2022
Q1 | $1.34M | Buy |
2,442
+391
| +19% | +$206K | 0.06% | 265 |
|
|
2021
Q4 | $1.35M | Buy |
2,051
+42
| +2% | +$26.4K | 0.06% | 287 |
|
|
2021
Q3 | $1.25M | Sell |
2,009
-100
| -5% | -$67.2K | 0.06% | 302 |
|
|
2021
Q2 | $1.33M | Sell |
2,109
-33
| -2% | -$18.2K | 0.06% | 294 |
|
|
2021
Q1 | $1.05M | Buy |
2,142
+656
| +44% | +$329K | 0.06% | 317 |
|
|
2020
Q4 | $743K | Buy |
1,486
+264
| +22% | +$118K | 0.07% | 325 |
|
|
2020
Q3 | $480K | Buy |
1,222
+18
| +1% | +$6.66K | 0.05% | 438 |
|
|
2020
Q2 | $398K | Sell |
1,204
-144
| -11% | -$41.7K | 0.04% | 504 |
|
|
2020
Q1 | $327K | Buy |
1,348
+75
| +6% | +$19.6K | 0.04% | 500 |
|
|
2019
Q4 | $332K | Hold |
1,273
| – | – | 0.03% | 634 |
|
|
2019
Q3 | $346K | Buy |
1,273
+34
| +3% | +$9.46K | 0.03% | 583 |
|
|
2019
Q2 | $341K | Buy |
1,239
+302
| +32% | +$74.4K | 0.03% | 577 |
|
|
2019
Q1 | $210K | Sell |
937
-216
| -19% | -$44.6K | 0.02% | 757 |
|
|
2018
Q4 | $214K | Hold |
1,153
| – | – | 0.03% | 664 |
|
|
2018
Q3 | $288K | Hold |
1,153
| – | – | 0.03% | 597 |
|
|
2018
Q2 | $251K | Sell |
1,153
-44
| -4% | -$9.07K | 0.03% | 634 |
|
|
2018
Q1 | $229K | Buy |
+1,197
| New | +$221K | 0.03% | 637 |
|
Other funds holding IDXX
VCM
VPM
Wedbush Securities's IDXX Position: Q1 2026 in Review
Wedbush Securities increased its Idexx Laboratories (IDXX) stake by 66% in Q1 2026, buying an estimated $773K and bringing the position to 3,037 shares worth $1.71M. The position accounts for 0.05% of the portfolio, ranked #306.
Wedbush Securities first reported a position in IDXX in Q1 2018 and has held it in 33 quarters since. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.
- Wedbush Securities held 3,037 shares of Idexx Laboratories worth $1.71M as of Q1 2026.
- Wedbush Securities bought 1,205 Idexx Laboratories shares in Q1 2026, an estimated $773K.
- Idexx Laboratories made up 0.05% of Wedbush Securities's portfolio in Q1 2026, its #306 holding.
- Wedbush Securities first reported a position in Idexx Laboratories in Q1 2018 and has held it in 33 quarters since.
- 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.
Based on Wedbush Securities's 13F filing for Q1 2026, filed 21 Apr 2026.